Write a one-page procurement charter before contacting suppliers. Keep patient treatment choices separate from commercial route selection.
What belongs in the charter?
Record:
- Current and intended states, locations and prescriber count.
- Current products and presentations, approved by clinical leadership for evaluation.
- Active patients, expected new starts and prescriptions due by product and state.
- Insurance-covered, self-pay and other access cohorts.
- Existing contracts, renewal dates, minimums, deposits and termination notice periods.
- The decision deadline and why the project exists.
- Whether the clinic purchases medicines, pays service fees, recommends pharmacies or controls prescription routing.
- The current failure baseline: unresolved prescriptions, delivery exceptions, refunds and staff handling time.
Use aggregate or appropriately de-identified information in procurement files. Keep patient-identifiable records in approved clinical systems, not in supplier-comparison spreadsheets or general-purpose research uploads.
How should you separate the money flows?
Use this proposed ledger structure:
| Ledger | Examples to record | What to establish |
|---|---|---|
| Clinic-controlled expenditure | Purchased stock; software; integration; staff handling; service fees | Can the clinic actually negotiate or remove it? |
| Patient expenditure | Medicine payment; shipping; supplies; separate care membership | Who collects it, and under what eligibility conditions? |
| Payer expenditure | Reimbursed medicine and dispensing amounts | Is the figure evidenced by actual adjudication or merely estimated? |
| Contingent exposure | Deposits; guarantees; minimum commitments; termination charges | What remains payable after a service or regulatory interruption? |
Do not book patient medicine savings as clinic margin. A lower pharmacy price benefits the clinic financially only through an identified contractual or operational mechanism; model that mechanism rather than assuming it.
Should all patients follow the same access route?
Do not start with that assumption. Build separate coverage and self-pay workflows, then let the clinical and access teams determine the appropriate options for each cohort.
For example, CMS describes the Medicare GLP-1 Bridge as a demonstration operating from July 1, 2026, through December 31, 2027, outside the usual Part D coverage and payment flow, with a central processor managing prior authorisation, claims and pharmacy payment in 2026. Clinics serving Medicare patients should investigate eligibility rather than automatically placing everyone into a manufacturer cash-pay workflow. CMS programme overview. (cms.gov)
Stage 1 exit document: a charter specifying the route decisions, patient cohorts, negotiable expenditure and baseline performance.
Explore the table row by row
A working view of the research
Clinic-controlled expenditure
- Examples to record
- Purchased stock; software; integration; staff handling; service fees
- What to establish
- Can the clinic actually negotiate or remove it?
Answers stay in this session unless you choose to save. No account needed.
Sources cited on this page
- cms.gov · Source 1 ↗https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge